Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

OBJECTIVES: The objective of this study was to construct an early economic evaluation for acalabrutinib for relapsed chronic lymphocytic leukaemia (CLL) to assist early reimbursement decision making. Scenarios were assessed to find the relative impact of critical parameters on incremental costs and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Appl Health Econ Health Policy
Main Authors: Vreman, Rick A., Geenen, Joost W., Hövels, Anke M., Goettsch, Wim G., Leufkens, Hubert G. M., Al, Maiwenn J.
Format: Artigo
Jezik:Inglês
Izdano: Springer International Publishing 2019
Teme:
Original Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885502/
https://ncbi.nlm.nih.gov/pubmed/31317510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-019-00496-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki